Skip to main content

PREMOM Clinical Study

We have conducted a prospective clinical study to demonstrate sensitivity and specificity of circulating RNA for the early screening of preeclampsia and other pregnancy complications

ClinicalTrials.gov Identifier: NCT04990141

blood test icon
medical consultation

PROSPECTIVE CLINICAL STUDY

We have conducted a multicenter study involving 14 hospitals and more than 100 health professionals dedicated to the recruitment of pregnant women

100

PATIENT ENROLLMENT ACHIEVED

9,600

Women recruited

9,583

Women who have completed the study

26,185

Total samples

We have enrolled more than 9,500 pregnant women and collected more than 26,000 peripheral blood samples at three specific points during pregnancy

Laboratory
Three trimester of pregnancy infographic
Three trimester of pregnancy infographic

PREECLAMPSIA SCREENING TEST

This clinical trial has enabled the development of a blood test to predict pregnancy complications early before the first symptoms appear

Blood sample processing icon

Blood Sample Processing

Isolating RNA molecules circulating in peripheral blood

NGS icon

NGS sequencing

Decoding all the RNA molecules isolated using innovative technologies

Molecular profiling icon

Molecular profiling

Unveiling the biology underlying pregnancy based on the RNA profile

Preeclampsia prediction icon

Preeclampsia prediction

Risk assessment during the first trimester of pregnancy

Our research brings us closer to a world where pregnant women do not fear for their health

Click the button below for more information about taking part in the trial. We will provide you with all the information you may need and evaluate your eligibility, obligation free!

Simply contacting or responding to this announcement does not commit you to participate but only expresses your desire to obtain more information regarding this study

Maternal health